title: Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice.
abstract: HemCon bandage is an engineered chitosan acetate preparation designed as a hemostatic dressing, and is under investigation as a topical antimicrobial dressing. We studied its effects on healing of excisional wounds that were or were not infected with Staphylococcus aureus, in normal mice or mice previously pretreated with cyclophosphamide (CY). CY significantly suppressed wound healing in both the early and later stages, while S. aureus alone significantly stimulated wound healing in the early stages by preventing the initial wound expansion. CY plus S. aureus showed an advantage in early stages by preventing expansion, but a significant slowing of wound healing in later stages. In order to study the conflicting clamping and stimulating effects of chitosan acetate bandage on normal wounds, we removed the bandage from wounds at times after application ranging from 1 hour to 9 days. Three days application gave the earliest wound closure, and all application times gave a faster healing slope after removal compared with control wounds. Chitosan acetate bandage reduced the number of inflammatory cells in the wound at days 2 and 4, and had an overall beneficial effect on wound healing especially during the early period where its antimicrobial effect is most important.
authors.affiliation: Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
authors.forename: Marina
authors.initials: M
authors.lastname: Burkatovskaya
authors.forename: Ana P
authors.initials: AP
authors.lastname: Castano
authors.forename: Tatiana N
authors.initials: TN
authors.lastname: Demidova-Rice
authors.forename: George P
authors.initials: GP
authors.lastname: Tegos
authors.forename: Michael R
authors.initials: MR
authors.lastname: Hamblin
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001458:Bandages; D001672:Biocompatible Materials / Q000494:pharmacology*; D048271:Chitosan / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D013207:Staphylococcal Skin Infections / Q000382:microbiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014945:Wound Healing / Q000187:drug effects*; D014946:Wound Infection / Q000382:microbiology / Q000517:prevention & control*
chemical_list: D000890:Anti-Infective Agents; D001672:Biocompatible Materials; D003520:Cyclophosphamide; D048271:Chitosan